A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT01266811 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study canceled based on results of different study with similar hypothesis, investigational agent, \& patient

Conditions

Interventions

Sponsor

Centocor, Inc.